Subscribe to Newsletter

February 2022 Issue of The Medicine Maker

Our latest issue introduces our new core topic sections focusing on small molecule manufacturing, bioprocessing, and cell and gene to keep you updated on the latest news in these important fields. In the cover feature, find out how video game technology is influencing a new generation of medicine – and how it could also help ensure quality in pharma manufacturing. We also have a special roundtable article featuring experts from IPEC-Americas about why the industry needs novel excipients. Additional topics in this issue include remote regulatory inspections, a look at how pharma has fared during the COVID-19 pandemic, and how nurse sharks are inspiring new therapeutics.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Business & Regulation Trends & Forecasts

The Magnificent Seven

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.
Discovery & Development Standards & Regulation

Who’s the Coolest?

| Angus Stewart

A best practice competition developed to encourage labs to pursue more efficient cold storage is now on for 2022.
Business & Regulation Advanced Medicine

Gearing Up for the 2022 Power List and More

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.
Business & Regulation Supply Chain

The Value of Dogged Determination

| Banks Bourne

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?
Manufacture Ingredients

Moving Away From “Quality by Fear”: Part I

| Stephanie Vine

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.
Business & Regulation Advanced Medicine

The Champions of Cell & Gene Therapy

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

Business & Regulation Business Practice

Inside the PenCycle Recycling Scheme

Novo Nordisk explains how its pilot scheme in the UK is helping to recycle injector pens.
Discovery & Development Drug Discovery

Join The Resistance

| Maryam Mahdi

Antimicrobial resistance is an ongoing challenge for the pharmaceutical industry. What solutions can be created to address the problem?
Discovery & Development Dosage Forms

Prizewinning Pillmaster

We talk to a young excipient expert who won The Journal of Pharmaceutical Sciences’ 2021 Outstanding Early Career Scientists award.
Discovery & Development Drug Discovery

Nurse Sharks and VNARs

How work on sharks could provide a highly effective weapon against new COVID variants
Business & Regulation COVID-19

Through the Fire

| Maryam Mahdi

How did pharma fare during 2021 and will the industry move forward as the pandemic continues to impact lives on a global scale?
Manufacture Contract Manufacturing Services

The Greener, Cleaner Path

| Stephanie Vine

We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.

Other issues of 2022